Early versus late fortification of breast milk in preterm infants: a systematic review and meta-analysis

Sriparna Basu1, Jaya Upadhyay2, Poonam Singh2

  • 1Department of Neonatology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, 249203, India. drsriparnabasu@rediffmail.com.

Insights

Early fortification of breast milk in preterm infants showed no significant impact on growth. However, early fortification was linked to longer hospital stays and a trend toward increased feed intolerance and necrotizing enterocolitis.

Area of Science:

  • Neonatal Nutrition
  • Pediatric Gastroenterology

Background:

  • Breast milk fortification is crucial for preterm infant nutrition.
  • Optimal timing for initiating breast milk fortification remains debated.

Purpose of the Study:

  • To compare the effects of early fortification (EF) versus late fortification (LF) of breast milk on preterm infant growth.
  • To evaluate adverse events and hospital stay duration associated with EF versus LF.

Main Methods:

  • Systematic review and meta-analysis of randomized and quasi-randomized controlled trials.
  • Included 3 trials with 309 preterm infants.
  • Data analyzed using RevMan 5.3; evidence quality assessed by GRADE.

Main Results:

  • No statistically significant differences in weight, length, or head circumference between EF and LF groups.
  • Total parenteral nutrition days were similar between groups.
  • Early fortification was associated with a significant increase in hospital stay (MD 4.29 days) and a non-significant trend towards increased feed intolerance and necrotizing enterocolitis (NEC).

Conclusions:

  • Very low-quality evidence indicates no significant difference in growth parameters between early and late breast milk fortification in preterm infants.
  • Early fortification may be associated with increased hospital stay and a potential trend towards higher rates of feed intolerance and NEC.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
172
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
663
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
167
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
190